Ligand Pharmaceuticals Inc (LGND)

Investing Cash Flow

-$144.78M

TTM · Period ending: · USD

LGND logo

LGND Investing Cash Flow

Latest reported-$144.78M
LGND TTM Cash from Investing ($19.40M → -$144.78M)
High-resolution chart · PNG

LGND investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-144,779,000
-476,563,000
-377,322,000
-397,841,000
-90,903,000
-134,995,000
-143,664,000
-115,325,000
-88,321,000
-26,006,000
-11,682,000
-8,682,000
29,997,000
60,292,000
163,624,000
135,195,000
97,802,000
79,289,000
30,523,000
-315,966,000
34,322,000
-11,773,000
231,648,000
550,671,000
388,117,000
680,677,000
466,918,000
805,399,000
557,630,000
-294,911,000
-423,269,000
-734,745,000
-713,031,000
-87,092,000
-84,177,000
-134,730,000
-73,114,000
-94,098,000
-143,192,000
-67,942,000
-99,385,000
-189,825,000
-112,862,000
-103,096,000
-76,659,000
-3,826,000
-2,027,000
-1,319,000
-1,636,000
-5,938,000
-4,974,000
-4,043,000
-6,166,000
-2,716,000
1,263,000
-944,000
1,287,000
1,982,000
-25,132,000
-21,825,000
-13,412,000
-12,509,000
14,540,000
25,586,000
30,362,000
24,775,000
24,768,000
23,654,000
7,005,000
-14,774,000
-24,424,000
-14,505,000
-20,557,000
11,776,000
343,837,000
522,704,000
528,609,000
520,154,000
196,865,000
2,239,000
17,038,000
8,852,000
-33,718,000
-15,999,000
-18,200,000
-26,361,000
19,611,000
-30,995,000
-36,778,000
-14,828,000
-24,619,000
-99,129,000
-102,542,000
-104,711,000
-105,245,000
1,312,000
-3,138,000
-2,471,000
-4,172,000
-2,717,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.